对苯二酚硫酸钾结构式
|
常用名 | 对苯二酚硫酸钾 | 英文名 | Potassium 2,5-dihydroxybenzenesulfonate |
|---|---|---|---|---|
| CAS号 | 21799-87-1 | 分子量 | 228.264 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C6H5KO5S | 熔点 | 251 °C (dec.)(lit.) | |
| MSDS | 中文版 美版 | 闪点 | N/A | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Evaluation of calcium dobesilate for its anti-cataract potential in experimental animal models.
Methods Find. Exp. Clin. Pharmacol. 32(3) , 171-9, (2010) The present study evaluated the protective action of calcium dobesilate (CDO) in various experimental models of cataract. CDO was studied in hydrocortisone-induced cataract in developing chick embryos and selenite-induced cataract in pups. CDO anti-cataract a... |
|
|
Phlebotonics for haemorrhoids.
Cochrane Database Syst. Rev. 8 , CD004322, (2012) Haemorrhoids are variceal dilatations of the anal and perianal venous plexus and often develop secondary to the persistently elevated venous pressure within the haemorrhoidal plexus (Kumar 2005). Phlebotonics are a heterogenous class of drugs consisting of pl... |
|
|
Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Exp. Eye Res. 115 , 96-105, (2013) Diabetic retinopathy (DR) is a hyperglycemia-induced ischemic disorder characterized by microvascular dysfunction and neovascularization. It is a leading cause of blindness in many countries, yet efficient drugs are limited now for prevention and treatment of... |
|
|
A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.
BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)
|
|
|
Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
Mol. Vis. 19 , 62-8, (2013) To determine the benefits of calcium dobesilate (CaD) administration on endothelial function and inflammatory status in patients with diabetic retinopathy through measurement of serum levels of endothelin-1 and high-sensitivity C-reactive protein (hsCRP).In a... |
|
|
Pharmacological treatment in patients with C4, C5 and C6 venous disease.
Phlebology 25 Suppl 1 , 35-41, (2010) A range of surgical, endovenous, physical and medical treatments are available for patients with chronic venous disease. The aim of this review was to evaluate the evidence for pharmacological agents used for the treatment of chronic venous disease.A literatu... |
|
|
Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor.
Neurosci. Lett. 491(1) , 1-7, (2011) Despite the deployment of multimodal therapies involving neurosurgical resection, radio- and polychemotherapy, the prognosis for glioblastoma patients remains poor. These tumors are pathologically characterized by their associated angiogenesis and diffuse bra... |
|
|
Calcium dobesilate and oxerutin: effectiveness of combination therapy.
Phlebology 25(2) , 66-71, (2010) Chronic venous insufficiency (CVI) is an important cause of discomfort and inability to work. Hydroxyethylrutosides (Venoruton); 0-[beta-hydroxyethyl]-rutosides) has been used for decades for the treatment of CVI. Studies have reported symptomatic relief and ... |
|
|
[Medical treatment of chronic venous disease: evolution or involution?].
Minerva Cardioangiol. 59(3) , 285-98, (2011) Chronic venous disease (CVD) is an important clinical condition with substantial epidemiological implications and socio-economic repercussions. In the Western world the consequences of its high prevalence, the costs of diagnosis and therapy, the significant l... |
|
|
The effects of calcium dobesilate on the mechanical function of rat hearts.
J. Cardiovasc. Surg. (Torino.) 50(3) , 395-401, (2009) Calcium dobesilate is an angio-protective agent that has positive effects on hemorheological parameters. It decreases blood and plasma viscosity, thrombocyte aggregation, and microvascular hyperpermeability. It is an antioxidant that increases endothelial-der... |